Projecten per jaar
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Yanmeng Wang actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
Projecten
- 1 Afgelopen
-
ANI365: S-adenosylmethioninesynthese als doelwit voor metabole kwetsbaarheid in multipel myeloom
1/11/23 → 31/10/24
Project: Fundamenteel
-
Targeting MAT2A alters the methylation landscape and DNA damage response in Multiple Myeloma, revealing novel combination strategies.
Van Hemelrijck, L. A., Wang, Y., Muylaert, C., Olsen, C., De Veirman, K., Vanderkerken, K., Menu, E. & De Bruyne, E., 7 feb 2025. 1 blz.Onderzoeksoutput: Poster
-
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia
Vandewalle, N., Satilmis, H., Verheye, E., Fan, R., Wang, Y., De Groof, T., Bridoux, J., kerre, T., De Beule, N., De Becker, A., De Bruyne, E., Menu, E., Vanderkerken, K., Breckpot, K., Devoogdt, N. & De Veirman, K., 15 apr 2024, In: Theranostics. 14, 7, blz. 2656-2674 19 blz.Onderzoeksoutput: Article › peer review
Open AccessBestand5 Citaten (Scopus)6 Downloads (Pure) -
S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma
Wang, Y., Muylaert, C., Wyns, A., Vlummens, P., De Veirman, K., Vanderkerken, K., Zaal, E., Berkers, C., Moreaux, J., De Bruyne, E. & Menu, E., 3 jan 2024, In: Haematologica. 109, 1, blz. 256-271 16 blz.Onderzoeksoutput: Article › peer review
Open AccessBestand7 Citaten (Scopus)25 Downloads (Pure) -
Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy
Wang, Y., Vandewalle, N., De Veirman, K., Vanderkerken, K., Menu, E. & De Bruyne, E., 11 jun 2024, In: Cell communication and signaling : CCS. 22, 1, 17 blz., 320.Onderzoeksoutput: Article › peer review
Open Access3 Citaten (Scopus) -
The therapeutic potential of targeting the metabolic enzyme MAT2A in multiple myeloma
Wang, Y., 2024, 228 blz.Onderzoeksoutput: PhD Thesis
Prijzen
-
Best Poster Presentation BHS 2025
Van Hemelrijck, Lien Ann (Recipient), Wang, Yanmeng (Recipient), Muylaert, Catharina (Recipient), Olsen, Catharina (Recipient), De Veirman, Kim (Recipient), Vanderkerken, Karin (Recipient), Menu, Eline (Recipient) & De Bruyne, Elke (Recipient), 7 feb 2025
Prijs: Prize (including medals and awards)
-
S-adenosylmethionine Biosynthesis is a Targetable Metabolic Vulnerability in Multiple Myeloma
Wang, Yanmeng (Recipient) & Menu, Eline (Recipient), 30 sep 2022
Prijs: Prize (including medals and awards)
Activiteiten
- 2 Talk or presentation at a conference
-
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia
Niels Vandewalle (Presenter), Hatice Satilmis (Contributor), Emma Verheye (Contributor), Yanmeng Wang (Contributor), Timo De Groof (Contributor), Nathan De Beule (Contributor), Tessa kerre (Contributor), Nathan De Beule (Contributor), Ann De Becker (Contributor), Elke De Bruyne (Contributor), Eline Menu (Contributor), Karin Vanderkerken (Contributor), Karine Breckpot (Contributor), Nick Devoogdt (Contributor) & Kim De Veirman (Contributor)
12 mrt 2024Activiteit: Talk or presentation at a conference
-
S-adenosylmethionine Biosynthesis is a Targetable Metabolic Vulnerability in Multiple Myeloma
Yanmeng Wang (Speaker)
30 sep 2022Activiteit: Talk or presentation at a conference